Integrating molecular diagnostics into patient care to truly personalize medicine is key to the future of successful medicine, in particular cancer care. That was the message delivered by Reinhard ...

This year's fourth annual C. Bruce Alexander Lecture in Pathology Education featured Danny A. Milner, Jr., M.D., MSC, FASCP, Chief Medical Officer, American Society for Clinical Pathology. The event ...

Clinical Pathology combines the theoretical and technical knowledge of human anatomy and physiology, clinical chemistry, genetics, immunology, microbiology, hematology, histocompatibility, cellular ...

Acquire a clinically relevant patient history from the treating physician. Compose a pertinent autopsy discussion clearly stating the primary and underlying causes of death. Present pediatric tumors ...

Anatomic and clinical pathology training at Baylor College of Medicine provides for an excellent, comprehensive pathology education that prepares trainees for academic, community, and private practice ...

Is Independent Clinical Research Possible in Low- and Middle-Income Countries? A Roadmap to Address Persistent and New Barriers and Challenges Multiple barriers to adequate cancer treatment in ...

One of the strongest assets of our program is our faculty. We are very proud of the outstanding educational experience they provide. They not only enjoy teaching but also serve as strong role models ...

ATLANTA and BOSTON, Sept. 15, 2025 (GLOBE NEWSWIRE) -- ABLi Therapeutics (“ABLi”), a biotechnology company developing therapeutics to address diseases that arise from activation of Abelson Tyrosine ...

The pathogenesis of tendinopathy and the primary biological change in the tendon that precipitates pathology have generated several pathoaetiological models in the literature. The continuum model of ...

Diagnostic pathology reports are crucial for accurate identification of disease (or lack thereof), yet due to the unstructured nature of these reports, they are not easily consumable by promising ...

(MENAFN- GlobeNewsWire - Nasdaq) ATLANTA and BOSTON, Sept. 15, 2025 (GLOBE NEWSWIRE) -- ABLi Therapeutics (“ABLi”), a biotechnology company developing therapeutics to address diseases that arise from ...